About the Event

Now that the Federal Government’s reforms to the Research and Development Tax Incentive (RDTI) have passed Parliament and will come into effect 1 July 2021, KPMG and AusBiotech will provide an update on what the changes mean in practice.

The changes end two-and-a-half years of uncertainty for those accessing the program and, while the calculations for companies will be dependent on the applicable corporate tax rate, the changes signify an important and positive shift in the appreciation of the benefits brought by R&D to support and incentivise growth in R&D and manufacturing as we recover from the pandemic.